Элла Фанг

How can prenatal testing become more accurate, affordable, and accessible to every expecting parent? In this MedTech World Asia 2026 Media Lounge interview in Hong Kong, Ella Fung, Co-Founder and CEO of Rosalind Dx, joins Lindsay Davis, Founder of FemTech Association Asia, to discuss how her company is working to close the accessibility gap in prenatal diagnostics. Drawing on her background in oncology research and her experience as a parent, Ella explains why Rosalind Dx is developing a PCR-based prenatal testing kit designed to make testing five times faster and cheaper to run for diagnostic laboratories that have been priced out of existing solutions. The conversation explores the limitations of expensive sequencing-based approaches, the importance of health equity in prenatal care, and how more cost-effective testing could help more families access accurate information about their baby’s health. Ella also shares Rosalind Dx’s plans to expand its US presence, with R&D operations remaining in Singapore, as the company prepares for its first market launch. Watch the full conversation to learn how Rosalind Dx is working to make accurate prenatal information more accessible to expecting parents. 📍 Event: MedTech World Asia 2026 | Hong Kong 🎙️ Guest: Ella Fung, Co-Founder & CEO, Rosalind Dx 🎤 Interviewer: Lindsay Davis, Founder, FemTech Association Asia Subscribe to MedTech World for more conversations about medical technology and healthcare innovation. #MedTechWorld #MTWAsia2026 #RosalindDx #PrenatalTesting #WomensHealth #FemTech #HealthEquity #Diagnostics #DigitalHealth #HealthcareInnovation